Suppr超能文献

用于沙门氏菌/微粒体试验的大鼠小肠制剂使用方法的评估。

Evaluation of a methodology for the use of preparations from rat small intestine in the Salmonella/microsome assay.

作者信息

Walters J M, Combes R D

出版信息

Mutat Res. 1983 Aug;113(5):393-402. doi: 10.1016/0165-1161(83)90229-7.

Abstract

A methodology is evaluated for the use in the Ames assay of a microsomal metabolising system derived from villous tip cells of rat small intestine. The procedure involved high frequency vibration of everted gut segments followed by gentle lysis and homogenisation. This technique, which has previously been shown to result routinely in high levels of cytochrome P450 and linked enzymes, has now been investigated for its ability to yield preparations capable of activating several promutagens in the Salmonella/plate incorporation test. The data obtained have been compared with results observed with standard rat liver metabolising fractions. In the presence of intestinal microsomes, 2-aminoanthracene, 2-aminofluorene, 2-acetylaminofluorene, aflatoxin B1, benzo[a]pyrene and cyclophosphamide all caused dose-related increases in revertants, the maximum yields of which were lower than those detected with liver microsomes or S9 mix. These and other differences in dose-responses have been discussed in relation to the levels of microsomal protein and cytochrome P450 plated and with respect to the activities of relevant enzymes in the tissue extracts.

摘要

对一种用于Ames试验的微粒体代谢系统进行了评估,该系统源自大鼠小肠绒毛顶端细胞。该程序包括对外翻肠段进行高频振动,然后进行轻柔裂解和匀浆。此前已证明该技术通常会产生高水平的细胞色素P450及相关酶,现在对其在沙门氏菌/平板掺入试验中产生能够激活多种前诱变剂的制剂的能力进行了研究。将获得的数据与用标准大鼠肝脏代谢组分观察到的结果进行了比较。在存在肠道微粒体的情况下,2-氨基蒽、2-氨基芴、2-乙酰氨基芴、黄曲霉毒素B1、苯并[a]芘和环磷酰胺均导致回复突变体数量呈剂量相关增加,其最大产量低于用肝脏微粒体或S9混合物检测到的产量。已针对所铺板的微粒体蛋白和细胞色素P450水平以及组织提取物中相关酶的活性,讨论了这些剂量反应差异及其他差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验